Veracyte Inc (VCYT)

Debt-to-assets ratio

Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Long-term debt US$ in thousands — — — — — — — — — — — — — — — — — — — —
Total assets US$ in thousands 1,344,100 1,315,410 1,300,040 1,275,020 1,234,330 1,200,070 1,137,820 1,124,940 1,161,110 1,157,120 1,156,420 1,125,960 1,144,200 1,173,590 1,187,820 1,186,360 1,027,440 1,025,140 457,163 454,151
Debt-to-assets ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

June 30, 2025 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1,344,100K
= 0.00

The analysis of Veracyte Inc’s debt-to-assets ratio over the observed period indicates a consistent value of zero across all reported dates, from September 30, 2020, through June 30, 2025. This persistent zero ratio suggests that the company has maintained a capital structure devoid of debt obligations relative to its total assets throughout this timeframe. Such a financial profile implies that Veracyte Inc may be financed entirely through equity or other non-debt sources, reflecting a conservative or debt-averse approach to capital management. The absence of debt-related leverage indicates limited financial risk associated with interest obligations and debt servicing, potentially enhancing the company's flexibility and financial stability. However, it also suggests that the company might not leverage debt to fund expansion or operational initiatives. Overall, the stable zero debt-to-assets ratio throughout the period underscores a debt-free operational model for Veracyte Inc, which can be viewed as a conservative financial stance with implications for growth strategy and risk profile.